UK markets closed

Siemens Healthineers AG (SHL.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
48.13-0.36 (-0.74%)
At close: 05:35PM CEST

Siemens Healthineers AG

Henkestrasse 127
Erlangen 91052
49 9131 84 3385

IndustryMedical Devices
Full-time employees66,000

Key executives

NameTitlePayExercisedYear born
Dr. Bernhard MontagPres, CEO & Chairman of Management Board2.88MN/A1969
Dr. Jochen SchmitzCFO & Member of Management Board1.86MN/A1966
Ms. Darleen CaronChief HR Officer & Member of Management Board1.37MN/A1964
Ms. Elisabeth StaudingerMember of Management Board & Head of Asia PacificN/AN/A1970
Mr. Marc KoebernickHead of Investor RelationsN/AN/AN/A
Mr. Michel TherinPres of Advanced TherapiesN/AN/A1961
Christian KlaussnerExec. VP of Fin.N/AN/AN/A
Andre HartungHead of ImagingN/AN/AN/A
Mr. Christopher A. TothHead of VarianN/AN/A1979
Carsten BertramHead of Advanced TherapiesN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Corporate governance

Siemens Healthineers AG’s ISS governance QualityScore as of 1 June 2022 is 3. The pillar scores are Audit: 2; Board: 6; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.